Kinetic Concepts (KCI) has launched a negative pressure product Prevena Incision Management System, designed specifically for management of surgically closed incisions, in Europe and Canada.
The studies have shown that the Prevena System may reduce the risk of post-operative complications, such as infection. The Prevena Incision Management System is available for use in hospitals throughout Europe and Canada. KCI estimates greater than three million procedures are performed each year worldwide that could benefit from treatment with the Prevena System, representing an opportunity greater than $1bn.
The Prevena Incision Management System is designed to create an environment that helps to promote healing by: removing exudate and potentially infectious material; helping to hold the edges of the incision together; stimulating perfusion; reducing edema and protecting the surgical site from external infectious sources.
The Prevena Incision Management System includes a single dressing, worn for the duration of therapy, which acts as a barrier to external infectious source. The Prevena System is indicated in the European Union and Canada for use over clean, closed incisions to manage the post-surgical environment and may reduce the likelihood of post-operative complications, such as surgical-site infection, dehiscence, hematoma and seroma. The system is intended for sale and single-patient use.
Mike Genau, global president of active healing solutions at KCI, said: “The Prevena Incision Management System is an important part of KCI’s broader Negative Pressure Therapy Platform,” “Prevena represents a revolutionary solution for surgical incisions at risk for post-operative complications. Prevena further diversifies our Active Healing Solutions portfolio, and we are excited to offer a product that may play a role in preventing and minimizing surgical complications.”
Nanne Kort, an orthopedic surgeon at Orbis Medical Park, the Netherlands, said: “The incision was clean and closed, exactly what I was hoping for in this co-morbid patient. When standard of care is applied, I typically see moisture at the incision area, which increases opportunity for infection. At-risk patients ambulating in a non-clinical setting are also key patients for Prevena Therapy as multiple dressing changes could lead to increased secondary infection.
“And finally, Prevena Therapy may potentially enable patients to be discharged earlier in comparison to standard of care, which may decrease their overall cost of treatment, an area I am interested in studying.”